侵侵向外公開治理武肺的藥用名單,包括Regeneron品牌人造抗體、Remdesivir瑞德西韋、Famotidine 啡莫替定以及Zinc, Vitamin D,Melatonin, Aspirin等雜項。86Please respect copyright.PENANACcwgkyKitO86Please respect copyright.PENANAx9918w6hrD
86Please respect copyright.PENANAfQgI5dJTSz
頭兩隻藥物(人造抗體及瑞德西韋)有數據支持可作治理武肺之用。86Please respect copyright.PENANASRMz0ae0qg
而啡莫替定主要是治理胃酸問題之用,但亦有非常微弱證據顯示可能有助治理武肺。86Please respect copyright.PENANAvw9NABuIGi
86Please respect copyright.PENANA0PfBYG3ox6
之餘其他雜項則在醫治武肺方面並無任何大關聯。86Please respect copyright.PENANApeHlZe0h6Y
86Please respect copyright.PENANAGsOVsijHgX
本篇文章,將會主要針對人造抗體及瑞德西韋兩者作深入淺出的探討。86Please respect copyright.PENANAS6CCNsiMKG
86Please respect copyright.PENANA6ggoUWjiH1
(圖2)Regeneron品牌的人造抗體是由兩款人造抗體組成,被證實能阻擋各變種武肺病毒(包括D614G變種)入侵身體。86Please respect copyright.PENANA3vkFo9e2GL86Please respect copyright.PENANAS6XCFa8iti
86Please respect copyright.PENANAFzD20o58A6
在動物實驗中,彌猴在三日前預先注射抗體的話,能有效阻擋武肺入侵細胞。86Please respect copyright.PENANAyfYdj6Aczn
而在無注射抗體的前提下,感染武肺一日後才注射打抗體的話,亦有效抵抗武肺入侵及減輕武肺對肺部帶來的傷害。86Please respect copyright.PENANASItx3MDtSu
86Please respect copyright.PENANAvhSJWKaybI
之於在倉鼠實驗中,兩日前預先注射抗體的話,亦有效能阻擋武肺入侵細胞。86Please respect copyright.PENANALiXppAbWUq
86Please respect copyright.PENANAoRKmIZ4XXU
而人類的臨床研究Phase3早在今年6月開始,現時正在進行的過程之中,9月尾他們曾向媒體表示注射2-4g會有正面效果以及一系列的表面數據,但未有學術文章刊出;86Please respect copyright.PENANAe5NhvTHI5v
這裡值得注意的是,侵侵所注射的份量為8g。86Please respect copyright.PENANAGW1leb77dj
86Please respect copyright.PENANAz1grpBzthS
在10月中,他們在英國RECOVERY TRIAL亦會有進一步的報告,到時將拭目以待,並會在當日作深入淺出的分析。86Please respect copyright.PENANAEPsd2mfw3Z
86Please respect copyright.PENANAIc1siCGgjH
(圖3)另一隻藥物Remdesivir 瑞德西韋,功效為抑制病毒入侵細胞後所需繁殖用的一隻蛋白質。86Please respect copyright.PENANAtVT7rjprre86Please respect copyright.PENANAV2g7QxcyE3
86Please respect copyright.PENANArAqrzNcWiU
臨床研究顯示可將平均康復時間由15日推前為11日,14日的死亡率由11.9%降至7.1%。86Please respect copyright.PENANA0iDpC9dfFX
86Please respect copyright.PENANAJ9GnpMdFHp
效果是否顯著,乃見仁見智。86Please respect copyright.PENANA0kbV3GH8lz
86Please respect copyright.PENANAQ0s3euF3pm
無論如何,人造抗體能阻擋各變種武肺病毒入侵身體,而瑞德西韋則能抑制病毒繁殖。86Please respect copyright.PENANAgwEP3BI0sO
現時以雙管齊下、兩方面入手的方式對付武肺,真心希望侵侵最終會無事出院!86Please respect copyright.PENANA0rc1ty0Wuw
86Please respect copyright.PENANACyiYdUJwwP
(圖4)此外,有不少人會把疫苗及人造抗體混淆在一起。86Please respect copyright.PENANAWJM8apAAUZ86Please respect copyright.PENANAvLCkUdJJsj
86Please respect copyright.PENANAjkM2TIL74U
疫苗是依賴自身免疫系統來製造抗體。抗體的製作需時,但身體可長遠地不斷生產。86Please respect copyright.PENANAwh0xgocJaa
而人造抗體則無需依賴自身免疫系統的協助,注射後會在短時出現效果,這亦是為何人造抗體的臨床研究相對上會比疫苗完成得更快。86Please respect copyright.PENANA1cCMS3u7nv
只不過人造抗體要長期保持一定水平的話,便要依靠長期不斷注射的方式,身體並無法製造出來。86Please respect copyright.PENANAKWk3RIPLb3
86Please respect copyright.PENANAWovIdXckpS
(圖5)以比喻的方式來說,假設侵侵想食薯條,人造抗體就等同到快餐店購買薯條,每一次想食的話便要到快餐店購買一包。86Please respect copyright.PENANAzWkJdv7mRl86Please respect copyright.PENANAl2faTKaPM3
86Please respect copyright.PENANAIBaT2EOobM
而疫苗就等同於買田製造薯仔生產線,薯條長遠能夠自給自足,只需注射一次及擁有足夠的時間。86Please respect copyright.PENANAOEoNpsqGKS
86Please respect copyright.PENANACqQdiPgmwl
86Please respect copyright.PENANA9doYauSA1v
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。86Please respect copyright.PENANAYDwR2vYb5h
86Please respect copyright.PENANAhrR2eSuzdr
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc86Please respect copyright.PENANAXl1rzG845Z
86Please respect copyright.PENANAzlBW8BHraR
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。86Please respect copyright.PENANAHlrBlJPGHC
86Please respect copyright.PENANApmLq9YTCTJ
Link:86Please respect copyright.PENANAdVz6mvTZEA
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio86Please respect copyright.PENANAZkhiVvnWrE
86Please respect copyright.PENANAwQkGFk2sWE
86Please respect copyright.PENANAqSEyJOLrKd
有興趣接收科學資訊的話,歡迎follow IG: potatopigtongue。86Please respect copyright.PENANA7ug2Fzop9u
copyright protection82PENANAy8q6IfaKnj
科普專欄–薯不揀單
Tags
- G: General Audiences
- PG: Parental Guidance Suggested
- PG-13: Parents Strongly Cautioned
- R: Restricted
RATED

Popularity
Follow Author
#68
深入淺出–侵侵治理武肺的藥物名單
Comments ( 0 )
No comments yet. Be the first!
Loading...